Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same
AssigneeMeso Scale Technologies, LLC.
InventorsJohn KENTEN, Mikayla HIGGINS, George SIGAL
Life of this patent
Estimating the term…
Abstract
The present invention is directed to assay methods and compounds and kits used in such assays.
Claims26
1-11. (canceled)
A method of measuring electrochemiluminescence comprising:
- (a) applying a potential to an electrode under conditions in which a complex that is in proximity to the electrode will emit electrochemiluminescence, wherein the complex comprises a target oligonucleotide and a labeled probe of Formula I or Formula II:
- wherein B is a nucleotide base, R is an electrochemiluminescent label, L1 is a linking group, L2 is a linking group, j is an integer between 0 and 11, k is an integer between 0 and 1, m is an integer between 0 and 11, and n is an integer between 0 and 5;
- wherein j is an integer between 0 and 11, k is an integer between 0 and 1, m is an integer between 0 and 11, n is independently an integer between 0 and 5, and R is an electrochemiluminescence label:
- wherein the oligonucleotide of the labeled probe of Formula I or Formula II is complementary to the target oligonucleotide;
- and
- (b) measuring the emitted electrochemiluminescence.
(canceled)
(canceled)
18-22. (canceled)
A oligonucleotide-containing compound selected from (I), (II), and (III):
- (I) a non-naturally occurring nucleic acid probe comprising an oligonucleotide, wherein the oligonucleotide is 14-24 nucleotides in length and comprises 14 or 15 contiguous nucleotides of 5′-GACAGAACTAGACAC-3′ (SEQ ID NO:33);
- (II) a non-naturally occurring oligonucleotide comprising 53 to 76 nucleotides, comprising at its 5′ end sequence 5′-GTTCTGTC-3′ and at its 3′ end sequence 5′-GTGTCTA-3′;
- (III) anchoring reagent of Formula X:
- wherein the oligonucleotide of Formula X comprises
- (SEQ ID NO:
- 35)
- 5'-AAGAGAGTAGTACAGCA-3'
25-32. (canceled)
(canceled)
(canceled)
37-39. (canceled)
A kit for conjugating a nucleic acid probe to a non-nucleic acid detection reagent to form a conjugate, comprising:
- (a) a heterobifunctional cross-linking agent comprising
- (i) a first reactive group capable of reacting with the detection reagent to attach the cross-linking agent to the detection reagent;
- and
- (ii) a second reactive group capable of reacting with the nucleic acid probe to attach the cross-linking agent to the nucleic acid probe, while being substantially unreactive to the detection reagent;
- (b) a first size separation device capable of separating the conjugate from unreacted nucleic acid probe;
- and
- (c) a nucleic acid binding fluorophore, wherein the fluorophore's fluorescence intensity increases when the fluorophore is bound to nucleic acid.
41-63. (canceled)
A method of conjugating a nucleic acid probe to a non-nucleic acid detection reagent to form a conjugate, wherein the method comprises (I), (II), or (III):
- (I):
- (a) reacting a detection reagent and a nucleic acid probe to form a conjugate;
- (b) using a size separation device to separate the conjugate from unreacted nucleic acid probe to form purified conjugate;
- (c) forming a test composition comprising a sample of the purified conjugate and a nucleic acid binding fluorophore selected for having a fluorescence intensity that increases when the fluorophore bound to nucleic acid;
- and
- (d) measuring the fluorescence of the test composition to determine an amount of nucleic acid probe in the purified conjugate;
- (II):
- contacting the detection reagent and the nucleic acid probe with a heterobifunctional cross-linking agent under conditions where the detection reagent reacts with a first reactive group of the cross-linking agent and the nucleic acid reacts with a second reactive group of the cross-linking agent to form the conjugate, wherein the heterobifunctional cross-linking agent comprises:
- (i) a first reactive group capable of reacting with the detection reagent to attach the cross-linking agent to the detection reagent and
- (ii) a second reactive group capable of reacting with the nucleic acid probe to attach the cross-linking agent to the nucleic acid probe, while being substantially unreactive to the detection reagent,
- wherein the method does not comprise purifying a reaction product of the detection reagent and the cross-linking agent, prior to the reaction of the cross-linking agent with the nucleic acid probe;
- (III):
- (a) contacting the detection reagent with a heterobifunctional cross-linking agent under conditions where the detection reagent reacts with a first reactive group of the cross-linking agent to form a first composition, wherein the heterobifunctional cross-linking agent comprises
- (i) a first reactive group capable of reacting with the detection reagent to attach the cross-linking agent to the detection reagent and
- (ii) a second reactive group capable of reacting with the nucleic acid probe to attach the cross-linking agent to the nucleic acid probe, while being substantially unreactive to the detection reagent;
- (b) contacting the first composition with the nucleic acid probe under conditions where the second reactive group in the cross-linking agent reacts with the nucleic acid probe to form the conjugate,
- wherein the method does not comprise purifying the reaction product of the detection reagent and the cross-linking agent, prior to the reaction of the cross-linking agent with the nucleic acid probe.
65-108. (canceled)
110-182. (canceled)
A method of measuring an analyte comprising:
- (a) binding the analyte to (i) a capture reagent in a binding domain on a surface, wherein the binding domain further comprises an anchoring reagent comprising an anchoring oligonucleotide and (ii) a conjugate comprising a detection reagent and a nucleic acid probe;
- thereby forming a complex in the binding domain comprising the capture reagent, the analyte and the conjugate;
- (b) extending the nucleic acid probe of the conjugate to form an extended sequence comprising an anchoring oligonucleotide complement that is complementary to the anchoring oligonucleotide and a detection sequence complement that is complementary to a detection oligonucleotide of a labeled probe;
- (c) binding the labeled probe comprising the detection oligonucleotide to the extended sequence;
- and
- (d) measuring the amount of labeled probe bound to the binding domain by performing the method of claim 1.
(canceled)
186-263. (canceled)
Dependencies are inferred from the claim text.